The CTSU is planning a webinar entitled, “Access to NCTN AYA Trials”, to highlight the need for sites to activate and offer cancer clinical trials to Adolescents and Young Adults (AYA). This webinar is set for Wednesday, April 22nd, 2015 at 4pm – 5pm EST.
NCI’s Dr. Nita Seibel will provide an overview on the NCTN AYA trials available on the CTSU, followed by a detailed summary of the COG-NRG ARST 1321 trial, (Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib), given by Study Co-Chair, Dr. Aaron Weiss from COG.
The agenda also will include:
- Suggestions from a few NCTN sites on how they’ve successfully opened AYA trials for both pediatric and adult patients.
- Information provided by NCI’s CIRB on their review processes for these trials and activation at sites treating pediatric or older adult patients.
- A brief recap by CTSU on site crediting for AYA trials.
The webinar will end with a Q&A session for you to ask questions from any of the webinar presenters about the trial and any issues regarding activating and accruing to AYA trials.
This webinar kicks off a new series of webinars by the CTSU. The goal of these webinars is to address key concerns that affect accrual to NCI-supported trials, and raise of awareness of trials among NCTN sites. The series is available to all sites and individuals interested in attending.
To attend the webinar on the NCTN AYA trials, simply go to the link below, and click register.